Next Generation Lipid-Based Nanoparticles Delivery Summit
19
Jul
-
21
Jul
2022
When
Boston
Massachusetts
USA
Where

Harness Safe & Efficacious Lipid-Based Delivery for Novel Therapeutics Beyond RNA & Hepatic Tissue The recent success of the mRNA-LNP vaccines fueled biopharma to explore lipid-based nanoparticles for advanced drug delivery.

Similar Events

You May Like

Event

Hanson Wade

0/5
(0)

Hanson Wade gives people the clarity to see where opportunity lies. We work in highly specialised fields to provide unmatched depth and quality of content. We work in sectors where quality of information is the difference between success and failure.

19 - 21 Jul 2022
In-Person

Speakers and Delegates
Industry Experts and Thought Leaders

Senior Director, Head of LNP Discovery
VP of Research
Bird Dogs Chair in Translational Cancer Research
Chief Technology Officer
Associate Director
Senior Principal Scientist

Sponsors and Exhibitors
Brand, Media and Promotional Partners

Precision NanoSystems Inc.

PNI is a global leader in ushering in the next wave of genetic medicines in infectious diseases, cancer, and rare diseases.

FUJIFILM Pharmaceuticals U.S.A., Inc.

Our mission is to deliver innovative drugs to the broader population of patients worldwide at reasonable cost. FUJIFILM Pharmaceuticals U.S.A., Inc. started its operation in 2008 as FUJIFILM’s global center for new drug development.

Lipoid, LLC

Lipoid as the world's leading cGMP manufacturer of purified lecithins and phospholipids for pharmaceutical use. Lipoid produces natural purified lecithins and phospholipids derived from soy and egg.

NanoImaging Services

Visualizing biomolecular structures through cryo-EM studies can provide insight into multiple stages of the drug development process, from target identification through formulation and manufacturing.

POLYPEPTIDE THERAPEUTIC SOLUTIONS, S.L.

PTS speciallizes in the design and manufacturing of polyamino-acid based delivery systems and bring value to our delivering solutions to clinical development & commercialization of therapeutic assets.

Organizer

Get emails from us

Thank you
Oops! Something went wrong